Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

April 1, 2024

Conditions
Postoperative PainPostoperative Return of Bowel Function
Interventions
DRUG

Lidocaine IV

They received IV infusion of 2 mg/kg per hour of lidocaine starting with skin incision, which was maintained until skin closure. This was done using a syringe pump with the calculated amount of lidocaine added to 50 ml of normal saline infused at a rate of 50 ml/hr.

DRUG

Placebo

0.9% normal saline infusion

Trial Locations (1)

11562

Cairo University Kasr Al Aini School of Medicine, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06433713 - Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections | Biotech Hunter | Biotech Hunter